Deceased donor kidney transplanted in childhood functioning well after 52 years

Giuseppina Spartà1, Karine Hadaya2, Luc Paunier3

  • 1Pediatric Nephrology Unit, University Children's Hospital, Zurich, Switzerland.

Insights

This case study highlights a pediatric kidney transplant recipient who, after 51 years, demonstrates exceptional long-term graft survival. The findings underscore the potential for successful pediatric kidney transplantation even with early, less advanced immunosuppression protocols.

Area of Science:

  • Pediatric nephrology
  • Transplantation immunology
  • Long-term outcomes research

Background:

  • Kidney transplantation in children was considered high-risk in 1970 due to poor long-term survival rates.
  • Early pediatric kidney transplants faced ethical considerations regarding risk versus benefit.

Observation:

  • A 6-year-old boy with hemolytic uremic syndrome received a deceased donor kidney transplant at age 6 years and 10 months.
  • He was maintained on moderate immunosuppression with prednisone and azathioprine.
  • At 58 years old, the patient remains well with stable renal function (eGFR 41 ml/min/1.73 m²) and no major complications, aside from benign skin lesions and adult-onset cardiac surgeries.

Findings:

  • The kidney transplant has functioned successfully for over 51 years, representing the longest-known deceased donor graft survival in a pediatric recipient.
  • Stable, unmodified immunosuppression predating calcineurin inhibitors, absence of rejection, and young donor age may have contributed to this exceptional outcome.
  • Patient adherence and a robust healthcare system were also crucial factors.

Implications:

  • This case demonstrates the feasibility of long-term graft survival in pediatric kidney transplantation, challenging earlier perceptions of risk.
  • It provides valuable insights into the long-term effects of early immunosuppression regimens.
  • The success offers hope and guidance for future pediatric transplant programs and patients.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
30
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
41
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
49
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
50
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
371
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
442